“apremilast” Archives

in
Entry Author Date Location
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal 08/26/19 New York
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
In a Huge Biopharma Shakeup, Bristol-Myers to Buy Celgene For $74B 01/03/19 National
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
Early Data for Celgene’s Oral Crohn’s Drug Gets Mixed Reaction 10/17/16 New York
Celgene Touts Data From Early Study of Oral GI Drug 09/12/16 Boston
Pfizer, Moving on From Allergan, Pays $5.2B For Anacor Pharma 05/16/16 San Francisco
East Coast Biotech Roundup: Collins, Disruptors, Biogen, & More 10/09/15 Boston
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
Celgene Drug Misses Mark in Spinal Arthritis Study 07/09/14 New York
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
Celgene Gets FDA Nod For Oral Arthritis Drug 03/21/14 New York
Page 1 of 1